Figure 1
Figure 1. Patient cohort selection. AITL, angioimmunoblastic T-cell lymphoma; ALCL, anaplastic large cell lymphoma; ATLL, adult T-cell leukemia/lymphoma; EATL, enteropathy-associated T-cell lymphoma; ENKTCL, extranodal NK/T-cell lymphoma, nasal type; HSTCL, hepatosplenic T-cell lymphoma; PTCL NOS, peripheral T-cell lymphoma not otherwise specified; SPTCL, subcutaneous panniculitis-like T-cell lymphoma; TCL U, T-cell lymphoma unspecified; T-LGL, T-cell large granular lymphocytic leukemia; T-PLL, T-cell prolymphocytic leukemia.

Patient cohort selection. AITL, angioimmunoblastic T-cell lymphoma; ALCL, anaplastic large cell lymphoma; ATLL, adult T-cell leukemia/lymphoma; EATL, enteropathy-associated T-cell lymphoma; ENKTCL, extranodal NK/T-cell lymphoma, nasal type; HSTCL, hepatosplenic T-cell lymphoma; PTCL NOS, peripheral T-cell lymphoma not otherwise specified; SPTCL, subcutaneous panniculitis-like T-cell lymphoma; TCL U, T-cell lymphoma unspecified; T-LGL, T-cell large granular lymphocytic leukemia; T-PLL, T-cell prolymphocytic leukemia.

Close Modal

or Create an Account

Close Modal
Close Modal